76 related articles for article (PubMed ID: 7415044)
1. [Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases].
Korman DB; Borisov AI; Maslova IA; Dobroskok LB
Vopr Onkol; 1980; 26(8):20-4. PubMed ID: 7415044
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy including anablastine in disseminated breast cancer].
Dement'eva IP; Ass NIa; Lipovich MM
Vopr Onkol; 1981; 27(5):10-3. PubMed ID: 6787799
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
Chang YC; Falkson G; Tormey DC; Crowley J
Am J Clin Oncol; 1982 Oct; 5(5):521-5. PubMed ID: 7180830
[TBL] [Abstract][Full Text] [Related]
5. Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin.
Catino A; Crucitta E; Latorre A; Sambiasi D; Calabrese P; Lorusso V
Oncol Rep; 2003; 10(1):163-7. PubMed ID: 12469164
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy in the adjuvant treatment of disseminated breast cancer].
Sviatukhina OV; Izmaĭlova GE
Vopr Onkol; 1981; 27(3):43-8. PubMed ID: 7222522
[TBL] [Abstract][Full Text] [Related]
7. [Use of adriablastin in the combination chemotherapy of disseminated breast cancer].
Korman DB; Borisov AI; Maslova IA; Pines EV
Vopr Onkol; 1981; 27(4):44-7. PubMed ID: 7233874
[TBL] [Abstract][Full Text] [Related]
8. [The diagnosis and treatment of bladder cancer metastases].
Kariakin OB; Grishin GN; Volodina TV
Urol Nefrol (Mosk); 1997; (2):22-5. PubMed ID: 9206877
[TBL] [Abstract][Full Text] [Related]
9. First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: a multicentre phase II study.
Vorobiof DA; Rapoport BL; Chasen MR; Slabber C; McMichael G; Eek R; Mohammed C
Breast; 2004 Jun; 13(3):219-26. PubMed ID: 15177425
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
Rossi D; Graziano F; Luzi Fedeli S; Fedeli A; Alessandroni P; Catalano V; Giordani P; Testa E; Catalano G
Minerva Med; 2002 Aug; 93(4):303-7. PubMed ID: 12207200
[TBL] [Abstract][Full Text] [Related]
12. [Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
Lichinitser MR; Assekritova IV; Gorbunova VA
Antibiotiki; 1977 Oct; 22(10):940-3. PubMed ID: 411416
[TBL] [Abstract][Full Text] [Related]
13. Use of an antiosteolytic agent in treatment of patients with bone metastases from breast cancer.
Dady PJ; Coombes RC; Smith IE; Parsons CA; Ford HT; Gazet JC; Henk JM; Nash AG; Powles TJ
Eur J Cancer (1965); 1980; Suppl 1():131-5. PubMed ID: 6459234
[No Abstract] [Full Text] [Related]
14. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
Zhou JC
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
[TBL] [Abstract][Full Text] [Related]
15. [Tamoxifen (Nolvadex): therapeutic effect in metastasizing breast cancer].
Mouridsen HT; Palshof T; Patterson J; Battersby L
Ugeskr Laeger; 1979 Jul; 141(31):2108-13. PubMed ID: 483408
[No Abstract] [Full Text] [Related]
16. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
[TBL] [Abstract][Full Text] [Related]
17. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of tamoxifen dose escalation in advanced breast cancer.
Goldhirsch A; Joss RA; Leuenberger U; Cavalli F; Ryssel HJ; Brunner KW
Am J Clin Oncol; 1982 Oct; 5(5):501-3. PubMed ID: 7180828
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B; Schabel-Moser R; Andel J; Fridrik M; Moik M; Mayer P; Russ G; Rass C; Greil R;
Onkologie; 2009 Feb; 32(1-2):18-24. PubMed ID: 19209014
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
